Page last updated: 2024-10-24

carprofen and Craniofacial Pain

carprofen has been researched along with Craniofacial Pain in 1 studies

carprofen: RN given refers to cpd without isomeric designation
carprofen : Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs.

Research Excerpts

ExcerptRelevanceReference
"Buprenorphine treatment reduced facial pain expression scores, improved mobility, stance and lameness scores and it did not supress the CFA-induced ankle swelling, contrary to carprofen."1.72Effects of buprenorphine on model development in an adjuvant-induced monoarthritis rat model. ( Abelson, KSP; Berke, MS; Fensholdt, LKD; Hestehave, S; Kalliokoski, O, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Berke, MS1
Fensholdt, LKD1
Hestehave, S1
Kalliokoski, O1
Abelson, KSP1

Other Studies

1 other study available for carprofen and Craniofacial Pain

ArticleYear
Effects of buprenorphine on model development in an adjuvant-induced monoarthritis rat model.
    PloS one, 2022, Volume: 17, Issue:1

    Topics: Analgesics, Opioid; Animals; Ankle Joint; Arthritis, Experimental; Behavior, Animal; Body Weight; Bu

2022